Pressmediaofindia
Related Articles
Hyderabad : Dr Reddy’s Laboratories Ltd has launched Bupropion Hydrochloride Extended-Release Tablets, USP (XL), 150 mg and 300 mg, a therapeutic equivalent generic version of Wellbutrin XL (Bupropion Hydrochloride Extended-Release) tablets in the US market.
According to a release issued by the Hyderabad-based company here on Wednesday, the Wellbutrin XL brand and generic had US sales of approximately $754 million on MAT for the most recent 12 months ending in July 2017, according to IMS Health. Wellbutrin XL, a trademark of GlaxoSmithKline LLC.
